InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Ives Jeffrey L., Director. Director active across 2 companies, notably Cara Therapeutics, Inc.. Aggregated, 10 disclosures have been recorded. Split: 0 buy · 3 sells. Total volume traded: €262k. Activity tracked since 3 June 2021. The latest transaction was filed on 3 June 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations10 total
35,500 shares0Common StockSEC:0001628280-26-041270:0
150,647 shares0Common StockSEC:0001415889-24-015760:0
39,149 shares@ US$0.72100.0% of flowCommon StockSEC:0001576885-23-000052:0
32,362 shares0Common StockSEC:0001209191-23-034327:0
3,600 shares@ US$9.0512.4% of flowCommon StockSEC:0001209191-22-042606:0
11,876 shares0Common StockSEC:0001209191-22-034626:0
8,180 shares@ US$16.0443.8% of flowCommon StockSEC:0001209191-21-064855
8,180 shares@ US$16.0450.0% of flowCommon StockSEC:0001209191-21-064855:0
7,200 shares0Common StockSEC:0001209191-21-038760:0
7,200 shares0Common StockSEC:0001209191-21-038760
10 of 10 declarations
About Ives Jeffrey L.
Ives Jeffrey L. serves as a Board Member at Cara Therapeutics, Inc. He brings expertise in corporate governance and strategy. His role involves overseeing company policies and contributing to strategic decision-making. With his experience, he helps guide the company's direction towards sustainable growth objectives.
